NCT04731740 2024-03-25
Pembrolizumab and Lenvatinib/Chemotherapy for Poorly Differentiated/Anaplastic Thyroid Cancer
Saint Petersburg State University, Russia
Phase 2 Withdrawn
Clinical Trials
4 trialsNCT03982537 2022-12-19
Effect of N-Acetyl Cysteine (NAC) on the Oral Microbiome
Wake Forest University Health Sciences
Phase 2 Withdrawn
NCT03673735 2021-05-10
ADHERE
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3 Withdrawn
NCT00095641 2013-11-08
S0225 Capecitabine in Treating Patients Who Have Undergone Surgery for Locally Recurrent or Persistent Head and Neck Cancer
SWOG Cancer Research Network
Phase 2 Withdrawn